• Es befinden sich keine Produkte im Warenkorb.

  • LOGIN

Literatur und weiterführende Links (FOOD 34-35)

Literaturliste

Aguilera CM, Mesa MD, Ramirez-Tortosa MC: Sunflower oil does not protect against LDL oxidation as virgin olive oil does in patients with peripheral vascular disease. Clin Nutr. 2004; 23:673-681.

Al-Solaiman Y, Jesri A, Mountford WK, et al: DASH lowers blood pressure in obese hypertensives beyond potassium, magnesium, and fibre. J Hum Hypertens. 2010; 24:237-246

Anand I, Chandrashekhan Y, De Giuli F, et al. Acute and chronic effects of propionyl-l-carnitine on the hemodynamics, exercise capacity, and hormones in patients with congestive heart failure. Cardiovasc Drugs Ther. 1998;12:291–299.

Anderson JL, May HT, Horne BD, et al: Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol 2010; 106:963-968.

Andersson SE, Edvinsson ML, Edvinsson L: Reduction of homocysteine in elderly with heart failure improved vascular function and blood pressure control but did not affect inflammatory activity. Basic Clin Pharmacol Toxicol 2005; 97:306-310.

Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med. 1997;336:1117–1124.

Arsenian MA. Carnitine and its derivatives in cardiovascular disease. Prog Cardiovasc Dis. 1997;40:265–286.

Awata N, Ishiyama T, Harada H, et al. The effects of coenzyme Q10 on ischemic heart disease evaluated by dynamic exercise test. In: Yamamura Y, Folkers K, Ito Y, eds. Biomedical and Clinical Aspects of Coenzyme Q. Vol 2. Amsterdam: Elsevier; 1980:247–254

Azadbakht L, Fard NR, Karimi M: Effects of the Dietary Approaches to Stop Hypertension (DASH) eating plan on cardiovascular risks among type 2 diabetic patients: a randomized crossover clinical trial. Diabetes Care. 2011; 34:55-57

Bagchi D. A review of the clinical benefits of coenzyme Q10. J Adv Med. 1997;10:139–148.

Baggio E, Gandini R, Plancher AC, et al. Italian multicenter study on the safety and efficacy of coenzyme Q10 as adjunctive therapy in heart failure. Mol Aspects Med. 1994;15:287–294.

Baker WL, Kluger J, White CM, et al: Effects of magnesium l-lactate on blood pressure in patients with an implantable cardioverter defibrillator. Ann Pharmacother 2009; 43:569-576.

Bashir Y, Sneddon JF, Staunton HA, et al. Effects of long-term oral magnesium chloride replacement in congestive heart failure secondary to coronary artery disease. Am J Cardiol. 1993;72:1156–1162.

Baur JA, Sinclair DA: Therapuetic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 2006; 5:493-506.

Becker DJ, Gordon RY, Halbert SC, et al. Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial. Ann Intern Med. 2009;150:830–839, W147-W149.

Becker DJ, Gordon RY, Morris PB, et al. Simvastatin vs therapeutic lifestyle changes and supplements: randomized primary prevention trial. Mayo Clin Proc. 2008;83:758–764.

Begg DP, Sinclair AJ, Stahl LA, et al: Hypertension induced by omega-3 polyunsaturated fatty acid deficiency is alleviated by alpha-linolenic acid regardless of dietary source. Hypertens Res 2010; 33:808-813.

Benvenga S, Amato A, Calvani M, Trimarchi F. Effects of carnitine on thyroid hormone action. Ann N Y Acad Sci. 2004;1033:158–167.

Billman GE, Hallaq H, Leaf A. Prevention of ischemia-induced ventricular fibrillation by omega 3 fatty acids. Proc Natl Acad Sci U S A. 1994;91:4427–4430.

Birjmohun RS, Hutten BA, Kastelein JJ, Stroes ES: Efficacy and safety of high-density lipoprotein cholesterol–increasing compounds: a meta-analysis of randomized controlled trials. J Am Coll Cardiol 2005; 45:185-197.

Boger RH, Bode-Boger SM, Thiele W: Restoring vascular nitric oxide formation by l-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease. J Am Coll Cardiol. 1998; 32:1336-1344

Bonaa KH, Njolstad I, Ueland PM: Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 2006; 354:1578-1588

Bor MV, Cevìk C, Uslu I, Güneral F, Düzgün E. Selenium levels and glutathione peroxidase activities in patients with acute myocardial infarction. Acta Cardiol. 1999;54:271-6.

Bramlage P, Pittrow D, Wittchen HU: Hypertension in overweight and obese primary care patients is highly prevalent and poorly controlled. Am J Hypertens 2004;17: 904–910.

Brevetti G, Chiariello M, Ferulano G, et al. Increases in walking distance in patients with peripheral vascular disease treated with l-carnitine: a double-blind, cross-over study. Circulation. 1988;77:767–783.

Brevetti G, Diehm C, Lambert D. European multicenter study on propionyl- l-carnitine in intermittent claudication. J Am Coll Cardiol. 1999;34:1618–1624

Brevetti G, Perna S, Sabba C, et al. Propionyl-l-carnitine in intermittent claudication: double-blind, placebo-controlled, dose titration, multicenter study. J Am Coll Cardiol. 1995;26:1411–1416

Brown L, Rosner B, Willett WW, Sacks FM. Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr. 1999;69:30–42.

Brown BG, Zhao XQ, Chait A: Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 2001; 345:1583-1592.

Brown L, Kroon PA, Das DK, et al: The biological responses to resveratrol and other polyphenols from alcoholic beverages. Alcohol Clin Exp Res 2009; 33:1513-1523

Buijsse B, Feskens EJM, Kok FJ, et al: Cocoa intake, blood pressure, and cardiovascular mortality. The Zutphen Elderly Study. Arch Intern Med 2006; 166:411-417.

Burdge GC, Jones AE, Wootton SA: Eicosapentaenoic and docosapentaenoic acids are the principal products of alpha-linolenic acid metabolism in young men. Br J Nutr. 2002; 88:355-364.

Burr ML, Ashfield-Watt PA, Dunstan FD, et al. Lack of benefit of dietary advice to men with angina: results of a controlled trial. Eur J Clin Nutr 2003; 57:193

Burr ML, Fehily AM, Gilbert JF, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: Diet and Reinfarction Trial (DART). Lancet. 1989;2:757–761.

Calo L, Bianconi L, Colivicchi F, et al. n-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial. J Am Coll Cardiol. 2005;45:1723–1728.

Caponnetto S, Canale C, Masperone MA, et al. Efficacy of l-propionyl-carnitine treatment in patients with left ventricular dysfunction. Eur Heart J. 1994;15:1267–1273.

Capuzzi DM, Guyton JR, Morgan JM: Efficacy and safety of an extended-release niacin (Niaspan): a long-term study. Am J Cardiol 1998; 82:74U-81U.

Carnes CA, Chung MK, Nakayama T, et al. Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation. Circ Res. 2001;89:E32–E38.

Carrero JJ, Lopez-Huertas E, Salmeron LM: Daily supplementation with omega-3 PUFAs, oleic acid, folic acid, and vitamins B6 and E increases pain-free walking distance and improves risk factors in men with peripheral vascular disease. J Nutr. 2005; 135:1393-1399.

Castelli WP, Doyle JT, Gordon T: Alcohol and blood lipids: the cooperative lipoprotein phenotyping study. Lancet 1977; 2:153-155.

Ceremuzynski L, Gebalska J, Wolk R, Makowska E: Hypomagnesemia in heart failure with ventricular arrhythmias: beneficial effects of magnesium supplementation. J Intern Med 2000; 247:78-86.

Cherchi A, Lai C, Angelino F, et al. Effects of l-carnitine on exercise tolerance in chronic stable angina: a multicenter, double-blind, randomized, placebo controlled crossover study. Int J Clin Pharmacol Ther Toxicol. 1985;23:569–572.

Chiuve SE, Korngold EC, Januzzi JL Jr, et al. Plasma and dietary magnesium and risk of sudden cardiac death in women. Am J Clin Nutr. 2011;93:253–260

Chobanian AV, Bakris GL, Black HR, et al: Seventh report of the Joint National Committee on Prevention, Evaluation and Treatment of High Blood Pressure. Hypertension 2003; 42:1206-1252.

Chopra RK, Goldman R, Sinatra ST, et al. Relative bioavailability of coenzyme Q10 formulations in human subjects. Int J Vitam Nutr Res. 1998;68:109–113.

Christensen JH, Gustenhoff P, Eilersen E, et al. n–3 Fatty acids and ventricular extrasystoles in patients with ventricular tachyarrhythmias. Nutr Res. 1995;15:1–8.

Christensen JH. n-3 fatty acids and the risk of sudden cardiac death: emphasis on heart rate variability. Dan Med Bull. 2003;50:347–367.

Chung MK. Vitamins, supplements, herbal medicines, and arrhythmias. Cardiol Rev. 2004;12:73–84.

Cicero AF, Derosa G, Manca M, etal. Different effect of psyllium and guar dietary supplementation on blood pressure control in hyperten­sive overweight patients: a six-month, randomized clinical trial. Clin Exp Hypertens. 2007;29:383–394.

Cohen N, Alon I, Almoznino-Sarafian D, et al: Metabolic and clinical effects of oral magnesium supplementation in furosemide-treated patients with severe congestive heart failure. Clin Cardiol 2000; 23:433-436

Corr PB, Gross RW, Sobel BE. Amphipathic metabolites and membrane dysfunction in ischemic myocardium. Circ Res. 1984;55:135–154.

Cosgrove M, Flynn A, Kiely M. Consumption of red meat, white meat and processed meat in Irish adults in relation to dietary quality. Brit J Nutr. 2005;93:933–942.

Cosgrove M, Flynn A, Kiely M. Impact of disaggregation of composite foods on estimates of intakes of meat and meat products in Irish adults. Public Health Nutr. 2005;8:327–337.

Crane FL, Navas P. The diversity of coenzyme Q function. Mol Aspects Med. 1997;18(suppl):S1–S6.

Daviglus ML, Stamler J, Orencia AJ: Fish consumption and the 30-year risk of fatal myocardial infarction. N Engl J Med 1997; 336:1046-1053.

de Lorgeril M, Renaud S, Mamelle N, et al. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet. 1994;343:1454–1459.

de Lorgeril M, Salen P, Martin JL, et al. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation. 1999;99:779–785

Deckert J. Propionyl-l-carnitine for intermittent claudication. J Fam Pract. 1997;44:533–534.

Deutsche Hochdruckliga e. V. – Deutsche Hypertonie Gesellschaft, Leitlinien zur Behandlung der arteriellen Hypertonie 2008. Verfügbar unter: http://www.hochdruckliga.de/(eingesehen am 07.07.2021)

DGE (Deutsche Gesellschaft für Ernährung): Ernährungsbericht 2008. DGE, Bonn

Di Lisa F, Menabo R, Siliprandi N. l-Propionyl-carnitine protection of mitochondria in ischemic rat hearts. Mol Cell Biochem. 1989;88:169–173.

Dietrich M, Traber MG, Jacques PF, et al: Does gamma-tocopherol play a role in the primary prevention of heart disease and cancer? A review. J Am Coll Nutr 2006; 25:292-299.

Digiesi V, Cantini F, Oradel G, et al: Coenzyme Q10 in essential hypertension. Mol Aspects Med 1994; 15(suppl):257-263.

Doutreleau S, Mettauer B, Piquard F, et al: Chronic but not acute oral l-arginine supplementation delays the ventilatory threshold during exercise in heart failure patients. Can J Appl Physiol 2005; 30:419-432.

Eslami M, Badkoubeh RS, Mousavi M, et al. Oral ascorbic acid in combination with beta-blockers is more effective than beta-blockers alone in the prevention of atrial fibrillation after coronary artery bypass grafting. Tex Heart Inst J. 2007;34:268–274

Estruch R, Martínez-González MA, Corella D: Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial. Ann Intern Med 2006; 145:1-11.

Falk E, Shah P, Fuster V: Coronary plaque disruption. Circulation 1995; 92:657-671

Ferrari R, Di Lisa F, de Jong JW, et al. Prolonged propionyl-l-carnitine pretreatment of rabbit: biochemical, hemodynamic and electrophysiological effects on myocardium. J Mol Cell Cardiol. 1992;24:219–232.

Ferrari R, Merli E, Cicchitelli G, et al. Therapeutic effects of l-carnitine and propionyl-l-carnitine on cardiovascular diseases: a review. Ann N Y Acad Sci. 2004;1033:79–91.

Folkers K, Vadhanavikit S, Mortensen SA. Biochemical rationale and myocardial tissue data on the effective therapy of cardiomyopathy with coenzyme Q10. Proc Natl Acad Sci U S A. 1985;82:901–904

Fontanive P, Saponati G, Iurato A, et al: Effects of l-arginine on the Minnesota Living with Heart Failure Questionnaire quality-of-life score in patients with chronic systolic heart failure. Med Sci Monit 2009; 15:CR606-611.

Forman JP, Giovannucci E, Holmes MD, et al: Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 2007; 49:1063-1069.

Frei B, Kim MC, Ames BN. Ubiquinol-10 is an effective lipid-soluble antioxidant at physiological concentrations. Proc Natl Acad Sci U S A. 1990;87:4879–4883

From the Dietary Approaches to Stop Hypertension study, as published by the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure and the National High Blood Pressure Education Program Coordination Committee. The sixth report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. Arch Intern Med. 1997;157:2413–2446

Fung TT, Chiuve SE, McCullough ML, et al: Adherence to a DASH-style diet and risk of coronary heart disease and stroke in women. Arch Intern Med. 2008; 168:713-720.

Galan P, Kesse-Guyot E, Czernichow S, et al. Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial. BMJ 2010; 341:c6273

Galleano M, Pechanova O, Fraga CG: Hypertension, nitric oxide, oxidants, and dietary plant polyphenols. Curr Pharm Biotechnol 2010; 11:837-848.

Geelen A, Brouwer IA, Schouten EG, et al. Effects of n-3 fatty acids from fish on premature ventricular complexes and heart rate in humans. Am J Clin Nutr. 2005;81:416–420

Ghio S, Scelsi L, Latini R, et al. Effects of n-3 polyunsaturated fatty acids and of rosuvastatin on left ventricular function in chronic heart failure: a substudy of GISSI-HF trial. Eur J Heart Fail 2010; 12:1345

Ghirlanda G, Oradei A, Manto A, et al: Evidence of plasma CoQ10-lowering effect by HMG-CoA reductase inhibitors: a double-blind, placebo-controlled study. J Clin Pharmacol 1993; 33:226-229.

Gissi-HF Investigators, Tavazzi L, Maggioni AP, et al. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 2008; 372:1223.

Godwin KO. Abnormal electrocardiograms in rats fed a low selenium diet. Q J Exp Physiol Cogn Med Sci. 1965;50:282–288.

Gordon RY, Cooperman T, Obermeyer W, Becker DJ. Marked variability of monacolin levels in commercial red yeast rice products: buyer beware! Arch Intern Med. 2010;170:1722–1727.

Greenberg S, Frishman WH. Co-enzyme Q10: a new drug for cardiovascular disease. J Clin Pharmacol. 1990;30:596–608.

Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico : Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999; 354:447-455.

Guerrero-Romero F, Rodríguez-Morán M: The effect of lowering blood pressure by magnesium supplementation in diabetic hypertensive adults with low serum magnesium levels: a randomized, double-blind, placebo-controlled clinical trial. J Hum Hypertens 2009; 23:245-251.

Hallaq H, Sellmayer A, Smith TW, Leaf A. Protective effect of eicosapentaenoic acid on ouabain toxicity in neonatal rat cardiac myocytes. Proc Natl Acad Sci U S A. 1990;87:7834–7838

Hallaq H, Smith TW, Leaf A. Modulation of dihydropyridine-sensitive calcium channels in heart cells by fish oil fatty acids. Proc Natl Acad Sci U S A. 1992;89:1760–1764

Hallfrisch J, Behall K.M.: Mechanisms of the effects of grains on insulin and glucose responses. J Am Coll Nutr 2000; 19(suppl):320S-325S.

Hambrecht R, Hilbrich L, Erbs S, et al: Correction of endothelial dysfunction in chronic heart failure: additional effects of exercise training and oral l-arginine supplementation. J Am Coll Cardiol 2000; 35:706-713.

Hanninen SA, Darling PB, Sole MJ, et al: The prevalence of thiamin deficiency in hospitalized patients with congestive heart failure. J Am Coll Cardiol 2006; 47:354-361

Hatzistavri LS, Sarafidis PA,et al: Oral magnesium supplementation reduces ambulatory blood pressure in patients with mild hypertension. J Am Hypertension. 2009 Oct;22(10):1070-5

Head A. Treatment of intermittent claudication with inositol nicotinate. Practitioner. 1986;230:49–54.

Heber D, Yip I, Ashley JM, et al. Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement. Am J Clin Nutr. 1999;69:231–236.

Henderson L, Gregory J, Irving K. Energy, protein, carbohydrate, fat and alcohol intake. Volume 2. The Stationery Office;London: 2003. The National Diet and Nutrition Survey: adults aged 19 to 64 years

Hiatt W: Risk factor modification in intermittent claudication: effect on life expectancy and walking capacity. Eur Heart J Suppl. 2002; 4(suppl B):B50-B54

Hinderliter AL, Babyak MA, Sherwood A, Blumenthal JA. The DASH diet and insulin sensitivity. Curr Hypertens Rep. 2011;13:67–73

Holguin F, Tellez-Rojo MM, Lazo M, et al. Cardiac autonomic changes associated with fish oil vs soy oil supplementation in the elderly. Chest. 2005;127:1102–1107.

Holick MF: Vitamin D deficiency. N Engl J Med 2007; 357:266-281.

Holub DJ, Holub BJ. Omega-3 fatty acids from fish oils and cardiovascular disease. Mol Cell Biochem. 2004;263:217–225.

Homocysteine Studies Collaboration : Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 2002; 288:2015-2022.

Hooper L, Thompson RL, Harrison RA, et al. Omega 3 fatty acids for prevention and treatment of cardiovascular disease. Cochrane Database Syst Rev 2004; :CD003177

Hu FB, Stampfer MJ, Manson JE: Dietary saturated fats and their food sources in relation to the risk of coronary heart disease in women. Am J Clin Nutr 1999; 70:1001-1008.

Huang HY, Appel LJ: Supplementation of diets with alpha-tocopherol reduces serum concentrations of gamma- and delta-tocopherol in humans. J Nutr 2003; 133:3137-3140.

Hung HC, Merchant A, Willett W, et al. The association between fruit and vegetable consumption and peripheral arterial disease. Epidemiology. 2003;14:659–665.

Hunt HA, Baker DW, Chin MH, Cinquegrani MP, Feldmanmd AM, Francis GS, Ganiats TG, Goldstein S, Gregoratos G, Jessup ML, Noble RJ, Packer M, Silver MA, Stevenson LW, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Jacobs AK, Hiratzka LF, Russell RO, Smith SC Jr: ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult. Circulation 2001; 104:2996–3007.

Intersalt Cooperative Research Group: Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Brit. Med. J. 1988; 297; 319–328

Jorde R, Sneve M, Torjeson P, Figenschau Y: No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year. J Intern Med 2009; 267:462-467

Joshipura KJ, Hu FB, Manson JE: The effect of fruit and vegetable intake on risk for coronary heart disease. Ann Intern Med 2001; 134:1106-1114.

Judy WV, Hall JH, Folkers K. Coenzyme Q10 withdrawal: clinical relapse in congestive heart failure patients. In: Folkers K, Littaru GP, Yamagami T, eds. Biomedical and Clinical Aspects of Coenzyme Q. Vol 4. Amsterdam: Elsevier; 1991:283–290.

Judy WV, Hall JH, Toth PD, et al. Double-blind double-crossover study of coenzyme Q10 in heart failure. In: Folkers K, Yamamura Y, eds. Biomedical and Clinical Aspects of Coenzyme Q. Vol 5. Amsterdam: Elsevier; 1986:315–322

Kang JX, Leaf A. Prevention and termination of beta-adrenergic agonist-induced arrhythmias by free polyunsaturated fatty acids in neonatal rat cardiac myocytes. Biochem Biophys Res Commun. 1995;208:629–636.

Kardinaal AF, Kok FJ, Kohlmeier L, Martin-Moreno JM, Ringstad J, Gómez-Aracena J, Mazaev VP, Thamm M, Martin BC, Aro A, Kark JD, Delgado-Rodriguez M, Riemersma RA, van ‘t Veer P, Huttunen JK. Association between toenail selenium and risk of acute myocardial infarction in European men. The EURAMIC Study. European Antioxidant Myocardial Infarction and Breast Cancer. Am J Epidemiol. 1997;145:373-9 (eingesehen am 27.10.2020)

Kawashima H: Receptor for 1,25-dihydroxyvitamin D in a vascular smooth muscle cell line derived from rat aorta. Biochem Biophys Res Commun 1987; 146:1-6.

Khatta M, Alexander BS, Krichten CM, et al. The effect of coenzyme Q10 in patients with congestive heart failure. Ann Intern Med. 2000;132:636–640.

Kleijnen J, Mackerras D: Vitamin E for intermittent claudication. Cochrane Database Syst Rev 2009.CD000987.

Klipstein-Grobusch K, den Breeijen , Grobbee DE: Dietary antioxidants and peripheral arterial disease: the Rotterdam Study. Am J Epidemiol 2001; 154:145-149.

Knoops KT, de Groot LC, Kromhout D, et al. Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: the HALE project. JAMA. 2004;292:1433–1439.

Knowles JW, Themistocles LA, Li J: Genetic susceptibility to peripheral arterial disease: a dark corner in vascular biology. Arterioscler Thromb Vasc Biol. 2007; 27:2068-2078

Korantzopoulos P, Kolettis TM, Kountouris E, et al. Oral vitamin C administration reduces early recurrence rates after electrical cardioversion of persistent atrial fibrillation and attenuates associated inflammation. Int J Cardiol. 2005;102:321–326.

Kromhout D, Giltay EJ, Geleijnse JM, Alpha Omega Trial Group. n-3 fatty acids and cardiovascular events after myocardial infarction. N Engl J Med 2010; 363:2015.

Landbo C, Almdal TP. Interaction between warfarin and coenzyme Q10. Ugeskr Laeger. 1998;160:3226–3227.

Lango R, Smolenski RT, Narkiewicz M, et al. Influence of l-carnitine and its derivatives on myocardial metabolism and function in ischemic heart disease and during cardiopulmonary bypass. Cardiovasc Res. 2001;51:21–29.

Langsjoen P, Langsjoen P, Willis R, Folkers R. Treatment of essential hypertension with coenzyme Q10. Mol Aspects Med. 1994;15(suppl):265–272.

Langsjoen PH, Langsjoen AM, Folkers K. Long-term efficacy and safety of coenzyme Q10 therapy for idiopathic dilated cardiomyopathy. Am J Cardiol. 1990;65:521–523.

Langsjoen PH, Langsjoen AM. Coenzyme Q10 in cardiovascular disease with emphasis on heart failure and myocardial ischemia.Asia Pac Heart J. 1998;7:160–168.

Langsjoen PH, Langsjoen AM. Overview of the use of CoQ10 in cardiovascular disease. Biofactors. 1999;9:273–284.

Langsjoen PH, Vadhanavikit S, Folkers K. Response of patients in classes III and IV of cardiomyopathy to therapy in a blind and crossover trial with coenzyme Q10. Proc Natl Acad Sci U S A. 1985;82:4240–4244

Lehr D. A possible beneficial effect of selenium administration in antiarrhythmic therapy. J Am Coll Nutr. 1994;13:496–498.

Lerman A, Burnett JC Jr, Higano ST, et al: Long-term l-arginine supplementation improves small-vessel coronary endothelial function in humans. Circulation 1998; 97:2123-2128.

Levitan EB, Wolk A, Mittleman M.A.: Relation of consistency with the dietary approaches to stop hypertension diet and incidence of heart failure in men aged 45 to 79 years. Am J Cardiol. 2009; 15:1416-1420 (eingesehen am 27.10.2020)

Li YC, Kong J, Wei M, et al: 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002; 110:2292.2238

Linseisen J, Kesse E, Slimani N, Bueno-De-Mesquita HB, Ocke MC, Skeie G, et al. Meat consumption in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohorts: results from 24-hour dietary recalls. Public Health Nutr. 2002;5:1243–1258.

Littarru GP, Ho L, Folkers K. Deficiency of coenzyme Q10 in human heart disease. II. Int J Vitam Nutr Res. 1972;42:413–434.

Lonn E, Bosch J, Yusuf S, et al: Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 2005; 293:1338-1347.

Lonn E, Yusuf S, Arnold MJ: Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 2006; 354:1567-1577.

López-Miranda J, Pérez-Jiménez F, Ros E, et al: Olive oil and health: summary of the II international conference on olive oil and health consensus report, Jaén and Córdoba (Spain) 2008. Nutr Metab Cardiovasc Dis 2010; 20:284-294.

Lu Z, Kou W, Du B, et al. Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction. Am J Cardiol. 2008;101:1689–1693.

Ludwig DS. Clinical update: the low-glycaemic-index diet. Lancet 2007; 369:890.

Mancia G, De Backer G, Dominiczak A et al 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007;25:1105–1187.

Mancini M, Rengo F, Lingetti M, et al. Controlled study on the therapeutic efficacy of propionyl-l-carnitine in patients with congestive heart failure. Arzneimittelforschung. 1992;42:1101–1104.

Mann JM, Davies MJ: Vulnerable plaque. Relation of characteristics to degree of stenosis in human coronary arteries. Circulation 1996; 94:928-931.

Marchioli R, Barzi F, Bomba E, et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione. Circulation 2002; 105:1897.

McGuinnes B, Todd S, Passmore AP, etal. Systematic review: blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia. J Neurol Neurosurg Psychiatry. 2008;79:4–5 (eingesehen am 27.10.2020)

Mellen PB, Walsh TF, Herrington DM: Whole grain intake and cardiovascular disease: a meta-analysis. Nutr Metab Cardiovasc Dis 2008; 18:283-290.

Mendoza CE, Rodriguez F, Rosenberg DG: Reversal of refractory congestive heart failure after thiamine supplementation: report of a case and review of literature. J Cardiovasc Pharmacol Ther 2003; 8:313-316.

Merchant A, Hu F, Spiegelman D, et al. Dietary fiber reduces peripheral arterial risk in men. J Nutr. 2003;133:3658–3663.

Mitrou PN, Kipnis V, Thiébaut AC, etal. Mediterranean dietary pat­tern and prediction of all-cause mortality in a US population: results from the NIH-AARP Diet and Health Study. Arch Intern Med. 2007;167:2461–2468.

Miura K, Greenland P, Stamler J, Liu K, Daviglus ML, Nakagawa H. Relation of vegetable, fruit, and meat intake to 7-year blood pressure change in middle-aged men: the Chicago Western Electric Study. Am J Epidemiol. 2004;591:572–580.

Mizutani K, Ikeda K, Kawai Y, Yamori Y: Protective effect of resveratrol on oxidative damage in male and female stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 2001; 28:55-59.

Monahan KD, Wilson TE, Ray CA. Omega-3 fatty acid supplementation augments sympathetic nerve activity responses to physiological stressors in humans. Hypertension. 2004;44:732–738.

Mori TA, Burke V, Puddey I, et al: The effects of omega-3 fatty acids and coenzyme Q10 on blood pressure and heart rate in chronic kidney disease: a randomized controlled trial. J Hypertens 2009; 27:1863-1872.

Morisco C, Trimarco B, Condorelli M. Effect of coenzyme Q10 therapy in patients with congestive heart failure: a long-term multicenter randomized study. Clin Investig. 1993;71(suppl):S34–S36.

Mortensen SA, Vadhanavikit S, Folkers K. Deficiency of coenzyme Q10 in myocardial failure. Drugs Exp Clin Res. 1984;10:497–502.

Mortensen SA. Perspectives on therapy of cardiovascular disease with coenzyme Q10. Clin Investig. 1993;71:116–123.

Mozaffarian D, Bryson CL, Lemaitre RN, et al. Fish intake and risk of incident heart failure. J Am Coll Cardiol 2005; 45:2015

Mozaffarian D, Lemaitre RN, King IB, et al. Circulating long-chain ω-3 fatty acids and incidence of congestive heart failure in older adults: the cardiovascular health study: a cohort study. Ann Intern Med 2011; 155:160

Mozaffarian D, Psaty BM, Rimm EB, et al. Fish intake and risk of incident atrial fibrillation. Circulation. 2004;110:368–373

Mozaffarian D. Fish and n-3 fatty acids for the prevention of fatal coronary heart disease and sudden cardiac death. Am J Clin Nutr. 2008;87:1991S–1996S.

Murabito JM, D’Agostino RB, Silbershatz H: Intermittent claudication: a risk profile from the Framingham Heart Study. Circulation. 1997; 96:44-49.

Nakagawa T, Sunamori M, Suzuki A. The myocardial distribution and plasma concentration of carnitine in patients with mitral valve disease. Surg Today. 1994;24:313–317.

Nakamura Y, Takahashi M, Hayashi J, et al. Protection of ischaemic myocardium with coenzyme Q10. Cardiovasc Res. 1982;16:132–137

Navas-Acien A, Bleys J, Guallar E. Selenium intake and cardiovascular risk: what is new? Curr Opin Lipidol. 2008;19:43-9.

Norris RB: “Flush-free niacin”: dietary supplement may be “benefit-free”. Prev Cardiol 2006; 9:64-65

Núñez-Córdoba JM, Valencia-Serrano F, Toledo E, et al. The Mediterranean diet and incidence of hypertension: the Seguimiento Universidad de Navarra (SUN) study. Am J Epidemiol. 2009;169:339–346

Onalan O, Crystal E, Daoulah A, et al. Meta-analysis of magnesium therapy for the acute management of rapid atrial fibrillation. Am J Cardiol. 2007;99:1726–1732.

Ondarroa M, Quinn P. Proton magnetic resonance spectroscopic studies of the interaction of ubiquinone-10 with phospholipid membranes. Int J Biochem. 1986;155:353

ORIGIN Trial Investigators, Bosch J, Gerstein HC, et al. n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. N Engl J Med 2012; 367:309

Papaliodis D, Boucher W, Kempuraj D, Theoharides TC: The flavonoid luteolin inhibits niacin-induced flush. Br J Pharmacol 2008; 153:1382-1387

Papoulidis P, Ananiadou O, Chalvatzoulis E, et al. The role of ascorbic acid in the prevention of atrial fibrillation after elective on pump myocardial revascularization surgery: a single center experience-pilot study. Interact Cardiovasc Thorac Surg. 2011;12:121–124.

Parati G, Stergiou GS, Asmar R et al; ESH Working Group on Blood Pressure Monitoring: Euro­pean Society of Hypertension practice guidelines for home blood pressure monitoring. J Hum Hy­pertens 2010;24:779–785.

Pepine CJ. The therapeutic potential of carnitine in cardiovascular disorders. Clin Ther. 1991;13:2–21.

Pfeifer M, Begerow B, Minne HW, et al: Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab 2001; 86:1633-1637.

Pierpoint ME, Judd D, Goldenberg I, et al. Myocardial carnitine in end-stage congestive heart failure. Am J Cardiol. 1989;64:56–60.

Raitt MH, Connor WE, Morris C, et al. Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial. JAMA. 2005;293:2884–2891.

Rauch B, Schiele R, Schneider S, et al. OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction. Circulation 2010; 122:2152

Rector TS, Bank AJ, Mullen KA, et al: Randomized, double-blind, placebo-controlled study of supplemental oral l-arginine in patients with heart failure. Circulation 1996; 93:2135-2141.

Regitz V, Shug AL, Fleck E. Defective myocardial metabolism in congestive heart failure secondary to dilated cardiomyopathy and coronary, hypertensive, and valvular heart disease. Am J Cardiol. 1990;65:755–760.

Reinhart KM, Coleman CI, Teevan C, etal. Effects of garlic on blood pressure in patients with and without systolic hypertension: a meta-analysis. Ann Pharmacother. 2008;42:1766–1771.

Ried K, Frank OR, Stocks NP, etal. Effect of garlic on blood pres­sure: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2008;16:8–13

Ried K, Sullivan T, Fakler P, et al: Does chocolate reduce blood pressure?. A meta-analysis. BMC Med 2010; 8:39

Rizos EC, Ntzani EE, Bika E, et al. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. JAMA 2012; 308:1024.

Rizos I. Three-year survival of patients with heart failure caused by dilated cardiomyopathy and l-carnitine administration. Am Heart J. 2000;139:S120–S123.

Rodrigo R, Vinay J, Castillo R, et al. Use of vitamins C and E as a prophylactic therapy to prevent postoperative atrial fibrillation. Int J Cardiol. 2010;138:221–228.

Ros E, Tapsell L, Sabaté J: Nuts and berries for heart health. Curr Atheroscler Rep 2010; 12:397-406.

Rosenfeldt FL, Haas SJ, Krum H, etal. Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials. J Hum Hypertens. 2007;21:297–306.

Rotondo S, Di Castelnuovo A, de Gaetano G: The relationship between wine consumptions and cardiovascular risk: from epidemiological evidence to biological plausibility. Ital Heart J 2001; 2:1-8.

Saari JT: Copper deficiency and cardiovascular disease: Role of peroxidation, glycation, and nitration. Can J Physiol Pharmacol 2000; 78:848–855.

Sabaté J, Ang Y: Nuts and health outcomes: new epidemiologic evidence. Am J Clin Nutr 2009; 89:1643S-1648S.

Sabba C, Berardi E, Antonica G, et al. Comparison between the effect of l-propionylcarnitine, l-acetylcarnitine and nitroglycerinin chronic peripheral arterial disease: a haemodynamic double blind echo-Doppler study. Eur Heart J. 1994;15:1348–1352.

Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. N Engl J Med. 2001;344:3–10.

Sacks D, Bakal C, Beatty PT: Position statement on the use of the ankle-brachial index in the evaluation of patients with peripheral vascular disease. J Vasc Interv Radiol. 2002; 13:353.

Schini-Kerth VB, Auger C, Etienne-Selloum N, Cataigneau T: Polyphenol-induced endothelium-dependent relaxations: role of NO and EDHF. Adv Pharmacol 2010; 60:133-175.

Schulman SP, Becker LC, Kass DA, et al: l-Arginine therapy in acute myocardial infarction. JAMA 2006; 295:58-64.

Schuschke DA: Dietary copper in the physiology of the microcirculation. J Nutr 1997;127:2274–2281.

Seligmann H, Halkin H, Hashomer T, Rauchfleisch S, Kaufmann N, Tal R, Motro M, Vered Z, Ezra D: Thiamine deficiency in patients with congestive heart failure receiving long-term furosemide therapy: a pilot study. Amer. J. Med. 1991; 91: 151–155.

Sellmayer A, Witzgall H, Lorenz RL, Weber PC. Effects of dietary fish oil on ventricular premature complexes. Am J Cardiol. 1995;76:974–977.

Serra-Majem L, Roman B, Estruch R. Scientific evidence of interven­tions using the Mediterranean diet: a systematic review. Nutr Rev. 2006;64:S27–S47.

Sesso HD, Buring JE, Christen WG: Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians’ Health Study II randomized controlled trial. JAMA 2008; 300:2123-2133

Sethi R, Wang X, Ferrari R, Dhalla NS. Improvement of cardiac function and beta-adrenergic signal transduction by propionyl l-carnitine in congestive heart failure due to myocardial infarction. Coron Artery Dis. 2004;15:65–71.

Siliprandi N, Di Lisa F, Pivetta A, et al. Transport and function of l-carnitine and l-propionylcarnitine: relevance to some cardiomyopathies and cardiac ischemia. Z Kardiol. 1987;76(suppl 5):3–40.

Simopoulos AP, Visioli F. Mediterranean Diets. Karger: Basel; 2000.

Singh RB, Niaz MA, Rastogi SS, et al: Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease. J Hum Hypertens 1993; 13:203-208.

Slattery ML, Jacobs DR, Jr., Hilner JE, Caan BJ, Van Horn L, Bragg C, et al. Meat consumption and its associations with other diet and health factors in young adults: the CARDIA study. Am J Clin Nutr. 1991;54:930–935.

Smith PJ, Blumenthal JA, Babyak MA, etal. Effects of the dietary approaches to stop hypertension diet, exercise, and caloric restric­tion on neurocognition in overweight adults with high blood pressure. Hypertension. 2010;55:1331–1338

Soja AM, Mortensen SA. Treatment of congestive heart failure with coenzyme Q10 illuminated by meta-analyses of clinical trials. Mol Aspects Med. 1997;18(suppl):S159–S168.

Soleas GJ, Diamandis EP, Goldberg DM: Wine as a biological fluid: history, production, and role in disease prevention. J Clin Lab Anal 1997; 11:287-313

Sommerfield T, Hiatt WR: Omega-3 fatty acids for intermittent claudication. Cochrane Database Syst Rev. 2004.CD003833

Song Y, Sesso HD, Manson JE, et al: Dietary magnesium intake and risk of incident hypertension among middle-aged and older US women in a 10-year follow-up study. Am J Cardiol 2006; 98:1616-1621

Spencer JC. Direct relationship between the body’s copper/zinc ratio, ventricular premature beats, and sudden coronary death. Am J Clin Nutr. 1979;32:1184–1185.

Spigset O. Reduced effect of warfarin caused by ubidecarenone [letter]. Lancet. 1994;344:1372–1373.

Steffen LM, Kroenke CH, Yu X, Pereira MA, Slattery ML, Van Horn L, et al. Associations of plant food, dairy product, and meat intakes with 15-y incidence of elevated blood pressure in young black and white adults: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Clin Nutr. 2005;82:1169–1177.

Stephens NG, Parsons A, Schofield PM, et al: Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996; 347:781-786.

Strain JJ. Newer aspects of micronutrients in chronic disease: Copper. Proc Nutr Soc 1994; 53:583–598.

Suzuki Y, Masumura Y, Kobayashi A, et al. Myocardial carnitine deficiency in congestive heart failure. Lancet. 1982;1:116

Tan J, Zhu W, Wang W, Li R, Hou S, Wang D, Yang L. Selenium in soil and endemic diseases in China. Sci Total Environ 2002; 284:227–235.

Tassani V, Cattapan F, Magnanimi L, Peschechera A. Anaplerotic effect of propionyl carnitine in rat heart mitochondria. Biochem Biophys Res Commun. 1994;199:949–953.

Taubert D, Roesen R, Lehmann C, et al: Effects of low habitual cocoa intake on blood pressure and bioactive nitric oxide: a randomized controlled trial. JAMA 2007; 298:49-60

Taubert D, Roesen R, Schömig E: Effect of cocoa and tea intake on blood pressure: a meta-analysis. Arch Intern Med 2007; 167:626-634.

Taylor AJ, Villines TC, Stanek EJ: Extended-release niacin or ezetimibe and carotid intima-media thickness. N Engl J Med 2009; 361:2113-2122

Taylor EN, Fung TT, Curhan GC: DASH-style diet associates with reduced risk for kidney stones. J Am Soc Nephrol. 2009; 20:2253-2259

Terés S, Barceló-Coblijn G, Benet M, et al: Oleic acid content is responsible for the reduction in blood pressure induced by olive oil. Proc Natl Acad Sci U S A 2008; 105:13811-13816

Tornwall ME, Virtamo J, Haukka JK: The effect of alpha-tocopherol and beta-carotene supplementation on symptoms and progression of intermittent claudication in a controlled trial. Atherosclerosis. 1999; 147:193-197.

Wagemakers JJ, Prynne CJ, Stephen AM, Wadsworth ME. Consumption of red or processed meat does not predict risk factors for coronary heart disease; results from a cohort of British adults in 1989 and 1999. Eur J Clin Nutr. 2009;63:303-11

Wang TJ, Pencina MJ, Booth SL: Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008; 117:503-511

Watanabe G, Tomiyama H, Doba N: Effects of oral administration of l-arginine on renal function in patients with heart failure. J Hypertens 2000; 18:229-234.

Watson PS, Scalia GM, Galbraith A, et al. Lack of effect of coenzyme Q10 on left ventricular function in patients with congestive heart failure. J Am Coll Cardiol. 1999;33:1549–1552

Welsh JA, Sharma A, Abramson JL, et al: Caloric sweetener consumption and dyslipidemia among US adults. JAMA 2010; 303:1490-1497

Whelton PK, He J, Appel LJ, et al. Primary prevention of hyperten­sion: clinical and public health advisory from the National High Blood Pressure Education Program. JAMA. 2002;288:1882–1888.

Whelton SP, Hyre AD, Pedersen B, etal. Effect of dietary fiber intake on blood pressure: a meta-analysis of randomized, controlled clinical trials. J Hypertens. 2005;223:475–481.

Wilson A, Harada R, Nair N: l-Arginine supplementation in peripheral arterial disease: no benefit and possible harm. Circulation. 2007; 116:188-195

Witte KK, Clark AL: Chronic heart failure and multiple micronutrient supplementation: realistic hope or idealistic conjecture?. Heart Fail Monit 2005; 4:123-129.

Witte KK, Nikitin NP, Parker A.C., et al: The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure. Eur Heart J 2005; 26:2238-2244.

Xiao YF, Kang JX, Morgan JP, Leaf A. Blocking effects of polyunsaturated fatty acids on Na+ channels of neonatal rat ventricular myocytes. Proc Natl Acad Sci U S A. 1995;92:11000–11004

Xun P, Hou N, Daviglus M, et al: Fish oil, selenium and mercury in relation to incidence of hypertension: a 20-year follow-up study. J Intern Med 2011; 270:175-186

Yamagami T, Shibata N. Bioenergetics in clinical medicine: studies on coenzyme Q10 and essential hypertension. Res Commun Chem Pathol Pharmacol. 1975;11:273–288.

Yamamura Y, Ishiyama T, Yamagami T, et al. Clinical use of coenzyme Q for treatment of cardiovascular disease. Jpn Circ J. 1967;31:168.

Yokoyama M, Origasa H, Matsuzaki M, et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 2007; 369:1090.

Yusuf S, Dagenais G, Pogue J, et al. Vitamin E supplementation and cardiovascular events in high-risk patients: the Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342:154–160.

Zhou Q, Zhou S, Chan E. Effect of coenzyme Q10 on warfarin hydroxylation in rat and human liver microsomes. Curr Drug Metab. 2005;6:67–81.

Pharmabrain Logo

European Union Trademark no. 006894216
US Patent and Trademark Office reg. no. 3,705,613
International Registration 1460744
All rights reserved.

Wir sind Pharmabrain.

Pharmabrain GmbH – Wir trainieren Ihren Erfolg
Gesundheitskommunikation, Teamentwicklung, Projektmanagement

Kontakt

Pharmabrain GmbH
Telefon: +49-30-28091515
E-Mail: support@pharmabrain.org

Research and Training Center

Schumannstr. 7b
D-10117 Berlin

Verwaltung

Schumannstr. 7a
D-10117 Berlin